Evolent Health (EVH) Accounts Payables (2015 - 2026)

Evolent Health's Accounts Payables history runs 12 years deep, the most recent figure standing at $63.0 million for Q1 2026.

• On a quarterly basis, Accounts Payables rose 8.98% year-over-year to $63.0 million in Q1 2026; TTM through Mar 2026 was $63.0 million, a 8.98% increase from a year earlier, with the FY2025 full-year figure at $59.8 million, down 37.75% from the prior year.
• Accounts Payables improved to $63.0 million in Q1 2026 per EVH's latest filing, from $59.8 million in the prior quarter.
• Across five years, Accounts Payables topped out at $96.6 million in Q2 2022 and bottomed at $39.0 million in Q2 2024.
• The 5-year median for Accounts Payables is $61.9 million (2022), against an average of $64.3 million.
• Across the five-year window, Accounts Payables jumped 142.14% in 2022 and tumbled 49.28% in 2024, its largest moves.
• Year by year, Accounts Payables stood at $57.2 million in 2022, then declined by 15.62% to $48.2 million in 2023, then jumped by 99.03% to $96.0 million in 2024, then tumbled by 37.75% to $59.8 million in 2025, then gained by 5.41% to $63.0 million in 2026.
• Per Business Quant, the three latest EVH Accounts Payables figures stand at $63.0 million (Q1 2026), $59.8 million (Q4 2025), and $72.2 million (Q3 2025).